Used in biomedical research to detect and quantify levels of human kallikrein 6 (KLK6) in biological samples such as serum, plasma, cerebrospinal fluid, and cell culture supernatants. This kit is particularly valuable in studies related to neurodegenerative diseases like multiple sclerosis and Alzheimer's disease, where KLK6 expression is elevated. It also supports cancer research, especially in ovarian, breast, and colon cancers, where KLK6 may serve as a potential biomarker for tumor progression. The assay enables high-sensitivity measurement, allowing researchers to monitor disease states, assess therapeutic responses, and explore the role of KLK6 in inflammation and tissue remodeling.